A new review in the World Journal of Gastrointestinal Pharmacology and Therapeutics examines the evolving landscape of manual assistive technologies and robotic platforms for colonoscopy, assessing whether these systems can improve technical performance, patient comfort, and procedural quality beyond conventional colonoscopy.
The review discusses several technologies, including ScopeGuide, Third Eye Retroscope, NaviAid, Endotics, NeoGuide, Invendoscope, and Aer-O-Scope. Rather than evaluating technological sophistication alone, the authors compare platforms using clinically meaningful endpoints such as cecal intubation rate, adenoma detection, procedure duration, patient discomfort, sedation requirement, complications, cost, and current level of clinical adoption.
Manual Assistive Technologies Show Greater Clinical Maturity
Manual adjuncts currently appear to have the strongest practical role in improving specific limitations of conventional colonoscopy. These technologies may assist with loop recognition and reduction, localization of the colonoscope, difficult navigation, and retrograde visualization of mucosal surfaces.
Across reported studies, manual assistive approaches generally achieved cecal intubation rates of approximately 93%–100%, although performance varied according to device, operator experience, patient selection, and study methodology.
These systems may be particularly relevant for difficult or previously incomplete colonoscopy, where improved scope navigation can potentially avoid repeat procedures or alternative investigations.
Robotic Colonoscopy: Promising but Heterogeneous
Robotic colonoscopy systems attempt to overcome limitations associated with conventional push-based colonoscope advancement. Depending on platform design, potential advantages include self-propulsion, reduced looping, improved navigation, lower force on the colonic wall, reduced discomfort, and potentially decreased sedation requirements.
Reported cecal intubation rates across robotic systems ranged approximately from 82% to 98%, demonstrating substantial variability between platforms.
Some systems have shown encouraging signals regarding patient comfort and reduced sedation, but evidence remains heterogeneous. Most robotic technologies have not yet demonstrated consistent superiority over modern conventional colonoscopy across all clinically important endpoints.
Technology Must Improve Meaningful Outcomes
A central message from the review is that technological novelty alone should not determine adoption. An advanced endoscopic platform should ideally demonstrate measurable improvement in outcomes such as:
- Cecal intubation and completion rates
- Adenoma and neoplasia detection
- Patient comfort
- Sedation requirements
- Procedure duration
- Safety and perforation risk
- Reliability in difficult anatomy
- Ease of learning and operator training
- Reprocessing and workflow efficiency
- Cost-effectiveness
A system that is technologically sophisticated but slower, expensive, difficult to maintain, or unable to improve detection and completion rates may provide limited clinical value.
Surgical Relevance
The distinction between endoscopy and minimally invasive surgery is becoming increasingly blurred. Colorectal surgeons routinely depend on colonoscopy for cancer diagnosis, lesion localization, preoperative assessment, surveillance, therapeutic polypectomy, and selection of patients for endoscopic versus surgical resection.
Advanced robotic endoluminal platforms may eventually extend beyond diagnostic colonoscopy toward complex mucosal resection, submucosal dissection, full-thickness intervention, suturing, and combined laparoendoscopic procedures.
For colorectal and GI surgeons, the immediate value of this review is therefore not that robotic colonoscopy should replace conventional colonoscopy, but that new platforms should undergo rigorous evaluation before widespread adoption.
Current Barriers to Robotic Colonoscopy
Several challenges continue to limit broad implementation:
Cost and capital investment: Robotic platforms must demonstrate sufficient clinical value to justify equipment, maintenance, and disposable expenses.
Technical complexity: Greater technological sophistication may introduce setup, troubleshooting, reprocessing, and training requirements.
Evidence quality: Many systems have been evaluated in relatively small studies, limiting confidence regarding comparative effectiveness.
Workflow integration: A technology must function efficiently within existing endoscopy-unit pathways.
Operator learning: Robotic assistance does not eliminate the requirement for knowledge of colorectal anatomy, lesion recognition, therapeutic decision-making, and complication management.
Future Direction
The most important future development may not simply be a colonoscope that advances robotically. Integration of robotic navigation, artificial intelligence, computer-assisted lesion detection, three-dimensional localization, force sensing, and therapeutic endoluminal instrumentation could eventually create more comprehensive endoscopic platforms.
Such systems may become increasingly relevant to the convergence of advanced endoscopy, natural-orifice intervention, robotic surgery, and minimally invasive colorectal treatment.
Clinical Takeaway
Manual colonoscopy-assist technologies currently have more established applications, particularly for navigation, loop reduction, and difficult colonoscopy. Robotic colonoscopy remains promising but has not yet demonstrated consistent superiority over standard colonoscopy. Future adoption should depend on high-quality comparative evidence demonstrating better completion, lesion detection, patient comfort, safety, workflow efficiency, or cost-effectiveness—not technological novelty alone.
Key Message
The 5 September 2026 update highlights the continuing convergence of endoscopy, robotics, and minimally invasive colorectal surgery. Manual assistive systems already provide practical solutions for difficult colonoscopy, while robotic platforms offer intriguing possibilities for improved navigation, comfort, and future therapeutic intervention.
The fundamental principle remains unchanged: new surgical and endoscopic technology should be adopted because it produces measurable improvements in patient care—not simply because it is technologically advanced.
